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Altered Patterns of Fungal Keratitis at a London
Ophthalmic Referral Hospital: An Eight-Year
Retrospective Observational Study
HON SHING ONG, SIMON S.M. FUNG, DAVID MACLEOD, JOHN K.G. DART, STEPHEN J. TUFT, AND
MATTHEW J. BURTON
 PURPOSE: In previous studies of fungal keratitis (FK)
from temperate countries, yeasts were the predominant
isolates, with ocular surface disease (OSD) being the
leading risk factor. Since the 2005–2006 outbreak of
contact lens (CL)-associated Fusarium keratitis, there
may have been a rise in CL-associated filamentary FK in
the United Kingdom. This retrospective case series inves-
tigated the patterns of FK from 2007 to 2014.
We compared these to 1994–2006 data from the same
hospital.
 DESIGN: Retrospective observational study.
 METHODS: All cases of FK presenting to Moorfields
Eye Hospital between 2007 and 2014 were identified.
The definition of FK was either a fungal organism isolated
by culture or fungal structures identified by light micro-
scopy (LM) of scrape material, histopathology, or
in vivo corneal confocal microscopy (IVCM). Main
outcome measure was cases of FK per year.
 RESULTS: A total of 112 patients had confirmed FK.
Median age was 47.2 years. Between 2007 and 2014,
there was an increase in annual numbers of FK (Poisson
regression, P[ .0001). FK was confirmed using various
modalities: 79 (70.5%) by positive culture, 16 (14.3%)
by LM, and 61 (54.5%) by IVCM. Seventy-eight patients
(69.6%) were diagnosed with filamentary fungus alone,
28 (25%) with yeast alone, and 6 (5.4%) with mixed fila-
mentary and yeast infections. This represents an increase
in the proportion of filamentary fungal infections from
the pre-2007 data. Filamentary fungal and yeast infec-
tions were associated with CL use and OSD, respectively.
 CONCLUSIONS: The number of FK cases has increased.
This increase is due to CL-associated filamentary FK.
Clinicians should be aware of these changes, which
warrant epidemiologic investigations to identify modifi-
able risk factors. (Am J Ophthalmol 2016;168:
227–236.  2016 The Author(s). Published by
Elsevier Inc. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/
4.0/).)
F
UNGAL KERATITIS (FK) IS AN IMPORTANT CAUSE OF
infectious keratitis and ocular morbidity worldwide.
The clinical diagnosis of FK can be difficult or
may not initially be considered, resulting in delayed treat-
ment. The available drugs have variable impact and in
nonresponsive cases, surgical excision of the infected
cornea is required to control the infection.1–4 Moreover,
visual outcomes of FK are often worse than for bacterial
keratitis.5,6
In tropical countries, fungi account for up to 67% of
corneal infections.7–14 Filamentary fungi associated with
trauma cause the majority of these infections. This has
also been reported in regions with subtropical
climates.5,15,16 In contrast, FK is a relatively rare clinical
problem in temperate countries such as the United
Kingdom (UK). A 2-year (2003–2005) national surveil-
lance study in the UK estimated a minimum average
incidence of FK at 0.32 (95% confidence interval [CI]
0.24–0.44) cases per million individuals per year.17
In that study, 23 of 39 (57.5%) were yeast (candida) infec-
tions and 17 of 39 (42.5%) were filamentary fungal infec-
tions. The majority of FK cases (25/39, 63.2%) were
associated with ocular surface disease (OSD). This associa-
tion was particularly strong for yeast infections, which all
had OSD. Trauma was associated with 11 of 39 (29%)
and contact lens (CL) use was reported in only 3 of 39 cases
(7.9%), which were all filamentary. This was consistent
with reports of FK in other high-income countries with
temperate climates.18–26 An earlier study from Moorfields
Eye Hospital, a large ophthalmic hospital serving London
and southeast England, reported on FK presenting over a
13-year period (1994–2006).27 During that time, yeast
infections accounted for the majority of FK cases and
were strongly associated with OSD. During the same
period CL-associated filamentary fungal keratitis was rela-
tively uncommon.
In 2005–2006, there was an outbreak of Fusarium kera-
titis in CL users, reported in the United States, Singapore,
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Hong Kong, Europe, and the French West Indies.28–34
Cases were thought to be associated with the use of the
ReNu with MoistureLoc (Bausch & Lomb, alexidine
dihydrochloride 0.00045%) CL disinfection solution.
Since this solution has been globally recalled on May
15, 2006, the incidence may have reduced.29 However,
the perception among clinicians in the UK is that the
number of FK cases has increased again in recent years,
with proportionately more CL-associated filamentary
fungi. To investigate this we conducted a retrospective
study of all confirmed cases of FK presenting to Moorfields
Eye Hospital from 2007 to 2014. We also compared these
data with data collected from the same institution be-
tween 1994 and 2006.
METHODS
THIS STUDY WAS A RETROSPECTIVE REVIEW OF MEDICAL
records. The protocol was approved by the Moorfields
Eye Hospital Clinical Research Management and Audit
Department (reference: CA13/CED/12). The study
adhered to the tenets of the Declaration of Helsinki.
 CASE ASCERTAINMENT: To identify cases we made the
assumption that all cases of fungal keratitis (suspected or
confirmed) would be commenced on topical antifungal
treatment. We queried the hospital pharmacy database
for the record numbers of all patients who were dispensed
any antifungal treatment between January 1, 2007
and December 31, 2014. The medical notes were retrieved
and reviewed to ascertain whether the individual met the
case definition for inclusion in this study.
 CASE DEFINITION: For the purpose of this study we
considered an individual with clinical features of suppura-
tive keratitis to be a case of FK if the individual met 1 or
more of the following criteria: (1) a fungal organism grown
from a corneal scrape or biopsy sample on 1 or more culture
media; (2) fungal elements present in light microscopy of a
corneal scrape sample; (3) fungal elements present in histo-
pathology of corneal biopsy tissue; (4) fungal elements
identified by in vivo confocal microscopy (IVCM).
 DATA COLLECTION: Data collected from the medical
record included: demographic information, country where
FK was acquired, potential risk factors (such as CL use,
topical steroid use, trauma), past ophthalmic history,
microbiology results, IVCM results, and visual acuity
outcome. The presenting visual acuity (VA) was routinely
measured with a Snellen chart at 6 meters, with spectacle
correction if available. The OSD group included patients
with dry eyes, corneal exposure, blepharitis, persistent
epithelial defects, or chronic ocular surface inflammatory
conditions (eg, atopic keratoconjunctivitis, mucous mem-
brane pemphigoid, Stevens-Johnson syndrome).
 LABORATORY INVESTIGATIONS: At Moorfields, speci-
mens for culture are typically obtained by scraping the base
and edges of corneal ulcers with a sterile, disposable 23 gauge
needle. Samples are smeared on a glass slide and stained for
microscopy. Samples are also inoculated onto a minimum of
blood agar and Sabouraud dextrose agar. In addition, several
other media are also frequently used: Robertson’s cooked
meat broth, brain-heart infusion, and non-nutrient agar.
All solid media are incubated at 37 C for a minimum of
1 week. Broths are usually cultured for 2 days and are then
subcultured on solid media for a minimum of 1 week. All
microbiological investigations were undertaken indepen-
dently in an external laboratory and cultured isolates are
sent to the UK Mycology Reference Laboratory for specia-
tion. For biopsies, a superficial lamellar disc of affected
cornea was taken under local anesthesia and sent for micro-
biological and histopathologic staining.35 Specimens from
biopsy or keratoplasty material were cultured from homoge-
nized tissue. The use of a panfungal polymerase chain reac-
tion (PCR) assay only entered our routine practice during
the last 24 months of the period studied. Therefore, for con-
sistency throughout the 2007–2014 study period it was not
used as an inclusion criterion for FK.
 IN VIVO CONFOCALMICROSCOPY: IVCM was performed
and interpreted by experienced clinicians using the HRT II/
RCMconfocalmicroscope (Heidelberg Engineering,Dossen-
heim, Germany).36 Typically, the ulcer is systematically sur-
veyed around its circumference andmore centrally at variable
depths to assess different levels of the cornea.Volume scans of
areas of interest were captured and stored for analysis.
 STATISTICAL ANALYSIS: Data were managed in Access
(Microsoft) and analyzed using STATA 13 (StataCorp
LP, Texas, USA). Differences in the distribution of cate-
gorical variables between groups were analyzed using the
x2 test or logistic regression. For continuous variables, dif-
ferences in distribution between groups were analyzed by
the Mann-Whitney test. Poisson regression was used to
analyze change in presentation rates. Multivariable logistic
regression was used to investigate risk factors for filamen-
tary vs yeast infection. Variables with significant associa-
tions on univariable analyses at a level of P < .05 were
included in the initial multivariable analysis. Nonsignifi-
cant terms were then removed from the multivariable
model in a step-wise manner, with only those with P <
.05 being retained.
To assess longer-term trends we compared the 2007–2014
data with data collected and previously reported from
the same hospital during the preceding 13 years (1994–
2006).27 This is a subset of the previously reported data
that only includes whole calendar years. The 1994–2006
series had more restricted inclusion criteria, as it only
included cases that were both UK-acquired and culture pos-
itive. It pre-dated the routine use of IVCM. To compare data
from the 2007–2014 series with the 1994–2006 series, we
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excluded cases in the 2007–2014 series that were acquired
outside the UK or did not have a positive culture.
RESULTS
 PATIENT CHARACTERISTICS: Between January 1, 2007
and December 31, 2014, 200 patients were prescribed an
antifungal treatment for suspected FK. Of these, 112
patients met the study inclusion criteria for FK, represent-
ing an average of 14 cases per year. Of the 88 patients who
were started on antifungal treatment but did not meet
the inclusion criteria for confirmed FK, 30 received
continued empirical treatment for fungal keratitis, 24
received continued treatment for a microbial keratitis of
unspecified cause, 29 were diagnosed with bacterial kera-
titis, 3 were diagnosed with herpetic keratitis, 1 was diag-
nosed with mycobacterium keratitis, and 1 was diagnosed
with a rheumatoid corneal melt.
All patients had unilateral infections. Their median age
was 47.2 years, and 46/112 (41.1%) were male (Table 1).
The majority of cases were acquired in the UK (91/112
[81.3%]), largely fromLondon and the east and the southeast
of England (Table 2). Of the 112 cases, 21 were acquired
outside the UK: 5/112 (4.5%) in other European countries,
3/112 (2.7%) in African countries, 7/112 (6.2%) in Asia,
and 6/112 (5.4%) in the Americas (Table 2). Overall, there
was strong evidence of an increase in the total annual num-
ber of cases presenting during the 2007–2014 period (Poisson
regression, P ¼ .0001, Figure 1, Upper left). When individ-
uals who acquired their infections outside the UK are
excluded from this analysis, there was still strong evidence
of an increase in the annual number of cases (Poisson regres-
sion, P¼ .0001, Figure 1, Upper left). There was no evidence
of an increase in the number of infections acquired outside
the UK during the 2007–2014 period (Poisson regression,
P ¼ .6, Figure 1, Upper left).
 DIAGNOSTIC MODALITY: Figure 2 illustrates the diag-
nostic modality by which the FK diagnosis was made for
the 112 cases. There was a positive culture in 79 patients:
73/112 (65.2%) from corneal scrapings, 6/112 (5.4%)
from corneal biopsy culture. One was culture positive
from both corneal scraping and biopsy samples. There
was 1 case in which the presence of fungal hyphae was
only confirmed by histopathology of the corneal button
(biopsy) removed following a penetrating keratoplasty. In
16 of the 112 patients (14.3%), fungal hyphae or yeasts
were identified by light microscopy; 4 of these were by light
TABLE 1. Demographic and Clinical Characteristics of 112 Patients With Fungal Keratitis Presenting to Moorfields Eye Hospital
Between 2007 and 2014
Variables
Filamentary Yeast Mixed All
78 (%) 28 (%) 6 (%) 112 (%)
Age, median (IQR)a 45.7 (31–56) 49.9 (44–66) 48.6 (28–56) 47.2 (36–57)
Male sexb 32 (41.0%) 13 (46.4%) 1 (16.7%) 46 (41.1%)
Risk factors
Contact lens 52 (66.7%) 7 (25.0%) 5 (83.3%) 64 (57.1%)
OSD 8 (10.3%) 16 (57.1%) 1 (16.7%) 25 (22.3%)
Ocular surgery 11 (14.1%) 14 (50.0%) 0 25 (22.3%)
Trauma 9 (11.5%) 4 (14.3%) 0 13 (11.6%)
Prior steroid use 17 (21.8%) 17 (60.7%) 2 (33.3%) 36 (32.1%)
Presenting VA (n ¼ 111)c
6/5–6/12 14 (18.0%) 2 (7.4%) 2 (33.3%) 18 (16.2%)
6/18–6/60 30 (38.5%) 5 (18.5%) 4 (66.6%) 39 (35.1%)
<_ CF 34 (43.6%) 20 (74.1%) 0 54 (48.7%)
Final best-corrected VA (n ¼ 106)d
6/5–6/12 47 (61.8%) 7 (29.2%) 5 (83.3%) 59 (55.7%)
6/18–6/60 18 (23.7%) 7 (29.2%) 1 (16.7%) 26 (24.5%)
<_ CF 11 (14.5%) 10 (41.7%) 0 21 (19.8%)
CF ¼ count fingers vision; IQR ¼ interquartile range; VA ¼ visual acuity.
aMann-Whitney test, for the comparison of filamentary and yeast infections: P ¼ .051.
bx2 test, for the comparison of filamentary and yeast infections for sex: P ¼ .6.
cx2 test, for the comparison of filamentary and yeast infections for presenting VA: P ¼ .024; presenting vision was not available in one indi-
vidual with learning disability.
dx2 test, for the comparison of filamentary and yeast infections for final VA: P ¼ .006; final best-corrected VA were only available in 106 in-
dividuals (6 individuals were lost to follow-up).
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microscopy alone. IVCM was performed for 80/112 pa-
tients (71.4%); of those, fungal structures were identified
in 61 (76.3%). In 28 patients the diagnosis of FK was
only made with IVCM (ie, negative on light microscopy,
biopsy histology, and culture). A total of 28 cases were
tested by panfungal PCR. Six were positive by PCR. Of
these, 4 were also positive by both culture and IVCM, 1
was also positive by IVCM, and 1 was also positive by cul-
ture. No cases of FK were detected by PCR alone.
 MICROBIOLOGICAL DIAGNOSIS: Overall, 78 of the 112
cases (69.6%) were filamentary fungal infections, 28 of 112
(25.0%) were yeast infections, and 6 of 112 (5.4%) mixed
filamentary and yeast infections. There was no evidence of
a difference in the pattern of organisms between those
acquired in the UK and those acquired outside the UK
(P ¼ .7). There was evidence (Poisson regression,
P¼ .005, Figure 1,Upper right) of an increase in the absolute
numbers of cases presenting attributable to filamentary fungi
acquired in the UK. However, there was no evidence of such
an increase in the number of yeast cases acquired in the UK
(Poisson regression, P ¼ .3, Figure 1, Upper right), or of an
increase in the numbers of filamentary fungi acquired outside
the UK (Poisson regression, P ¼ .9, Figure 1, Upper right).
This suggests that it is the increase in the absolute numbers
of filamentary fungi acquired in the UK that is driving the
increase in the overall number of FK cases being presented.
There was no evidence of a difference in the sex distribution
between filamentary fungal and yeast infections (P ¼ .6),
Table 1. The median age of people with yeast infections
was slightly higher than in filamentary cases; however, this
was not statistically significant (P ¼ .051, Figure 1, Middle
left). Of the 61 cases identified by IVCM, 58 had branching
filamentary hyphae (of which 27 were culture positive for
filamentary fungi) and 3 had large round bodies consistent
with a diagnosis of yeast (of which 1 was culture positive
for Candida spp) (Figure 3).
There were 90 fungal culture isolates (Table 3) from the 79
culture-positive cases. In 11 cases 2 fungal organisms were co-
cultured: 7 grew 2 different filamentary organisms and 4 grew
a filamentary organism and a yeast. Overall, 30/90 isolates
(33.3%) were yeasts and 60/90 (66.7%) were filamentary
fungi. Fusarium spp were the commonest filamentary fungi
isolated (33/79 cases, 41.8%), followed by Aspergillus spp
(9/79 cases, 11.4%). All the yeast isolates were subspecies
of Candida (30/79 cases, 38.0%). Bacterial co-infection was
present in 20 of the 112 cases (17.9%) (Table 4). In 1 case
Acanthamoeba was also co-cultured. There was no evidence
of a difference in the proportion of filamentary and yeast cases
that had a bacterial co-infection (P ¼ .5).
 CLINICALCOURSEANDTREATMENT: The presenting vi-
sual acuity was count fingers or less in 54 (48.7%) of the
affected eyes (Table 1). There was evidence that the
presenting vision was worse among the cases with yeast
infection (P ¼ .024). Visions at final follow-up were avail-
able in 106 individuals. By the final follow-up there was an
improvement in the vision of 74/106 eyes (69.8%), no
change in 16/106 (15.1%), and a deterioration in 16/106
(15.1%). The number of eyes with a visual acuity of count
fingers or less was 21 (20.0%) at the final follow-up. There
was no evidence to suggest that final visual acuities of pa-
tients diagnosed by positive cultures compared with patients
who had negative cultures (diagnosed by other modalities)
were different (P ¼ .50). At least 1 corneal graft procedure
was performed in 34/112 cases (30.4%): 27 had a therapeutic
keratoplasty, 14 had a penetrating keratoplasty, and 5 had a
lamellar keratoplasty for restoration of vision. Two patients
had a conjunctival flap and 4 eyes were eviscerated.
All patients were treated with topical antifungal agents.
During this 8-year period there was a change in the pattern
of prescribing for filamentary fungal infections (Figure 1,
Middle right). Initially most cases were treated with econa-
zole 1%. From 2009 there was increased use of voriconazole
TABLE 2. Regions of the United Kingdom and Other
Countries Where Fungal Keratitis Was Acquired, Presenting
Between 2007 and 2014
Regions/Countries n/112 (%)
United Kingdom 91 (81.3%)
Greater London 58 (63.7%)a
East of England 17 (18.7%)a
Southeast England 9 (9.9%)a
Southwest England 3 (3.3%)a
West Midlands 3 (3.3%)a
Northwest England 1 (1.1%)a
Europe
Malta 1 (0.9%)
Cyprus 1 (0.9%)
Spain 2 (1.8%)
Poland 1 (0.9%)
Americas
North America (Florida) 1 (0.9%)
Costa Rica 1 (0.9%)
Jamaica 1 (0.9%)
Ecuador 1 (0.9%)
Brazil 1 (0.9%)
Venezuela 1 (0.9%)
Asia
China 1 (0.9%)
India 2 (1.8%)
Bangladesh 1 (0.9%)
Indonesia 1 (0.9%)
Vietnam 1 (0.9%)
Cambodia 1 (0.9%)
Africa
Gambia 1 (0.9%)
Nigeria 1 (0.9%)
Algeria 1 (0.9%)
aFor UK regions the% values are calculated out of all 91 cases
acquired in the UK.
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1%. From 2013 onward there was a move away from vorico-
nazole 1%, to natamycin 5%. Yeast infections were usually
treated with topical amphotericin 0.015% or voriconazole
1%. One or more oral antifungal agents were used in 65/
112 cases (58%): voriconazole in 48/112 (42.9%), itracona-
zole in 14/112 (12.5%), and fluconazole in 10/112 (8.9%).
 RISK FACTORS: Several potential risk factors were
reported, including contact lens use, OSD, prior ocular
surgery, and a history of trauma (Table 1). Evidence for
the associations between the class of fungus isolated (yeast
or filamentary) and each of these risk factors for infection
are shown in Table 5. The use of contact lenses at the
time of onset of symptoms was reported by 64 of 112 indi-
viduals (57.1%) (Table 1). There was evidence that fila-
mentary fungal infections were more frequently
associated with contact lens use than were yeast infections
(Table 5). The types of contact lens used were: soft (for
vision), 56/64 (87.5%); therapeutic (bandage), 3/64
(4.7%); and rigid gas-permeable, 4/64 (6.3%). The type
FIGURE 1. Patterns of fungal keratitis observed in this study. (Upper left) Number of cases of fungal keratitis presenting each year
(2007–2014) subdivided into those acquired in the United Kingdom (UK) (91) and outside the UK (21). There was an increase with
time in cases acquired in the UK (Poisson regression P[ .0001) but not from outside the UK (Poisson regression P[ .6). (Upper
right) Number of cases of filamentary fungal infections, yeast infections, and mixed infections (filamentary and yeast) by year of
presentation. There was an increase with time in the number of cases of filamentary fungi acquired in the UK: Poisson regression
P [ .005. There were no other statistically significant changes with time. (Middle left) Number of cases of filamentary fungal
infections, yeast infections, and mixed infections (filamentary and yeast) by age group. (Middle right) Number of cases treated by
different topical antifungal drugs, by year of presentation. (Lower left) Number of cases acquired in the UK only, 1994–2014, subdi-
vided by a culture/nonculture diagnosis. There was an increase in the number of culture-positive, UK-acquired cases between 1994
and 2014: Poisson regression P[ .003.
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of contact lens used was not recorded in one individual.
Among the 56 wearing soft (for vision) contact lenses, 11
(19.6%) used daily disposable, 17 (30.4%) used fortnightly
disposable, and 25 (44.6%) used monthly disposable. The
pattern of wear of contact lenses was not recorded in 3 pa-
tients. Although the data on ‘‘risk’’ behavior were not sys-
tematically collected, of the soft (for vision) CL users, 4/
56 (7.1%) reported overnight use, 9/56 (16.1%) reported
swimming in lenses, and 11/56 (19.6%) reported showering
in lenses. All 3 cases associated with the use of therapeutic
CL had OSD. These lenses were being used for up to
1 month between lens changes.
There was evidence that filamentary fungal infections
were less frequently associated with OSD compared to yeast
infections (Tables 1 and 5). Of the 25 cases with prior
OSD, 6 (24%) had atopic keratitis, 4 (16%) blepharitis, 4
(16%) persistent epithelial defect, 3 (12%) Stevens-
Johnson syndrome, 3 (12%) exposure keratitis, 2 (8%)
mucus membrane pemphigoid, 1 (4%) dry eye disease, 1
(4%) ectodermal dysplasia, and 1 (4%) neurotrophic kera-
titis. A persistent epithelial defect was present in 16/112
cases (14.3%) cases prior to the onset of infection, 12 of
which had an additional underlying OSD diagnosis.
There was a history of prior ocular surgery in 25 of the
112 cases (22.3%) (Table 1). There was evidence that
filamentary fungal infections were less frequently associ-
ated with prior ocular surgery than were yeast infections
(Table 5). Previous ocular surgery included 8/112 (7.1%)
penetrating keratoplasties, 4/112 (3.6%) anterior lamellar
keratoplasties, 1/112 (0.9%) limbal stem cell allograft, 3/
112 (2.7%) cataract surgeries, 3/112 (2.7%) retinal detach-
ment surgeries, 1/112 (0.9%) phototherapeutic keratec-
tomy, 3/112 (2.7%) laser in situ keratomileusis, 1/112
(0.9%) corneal collagen cross-linking, and 1/112 (0.9%)
limbal relaxing incision procedure during cataract surgery.
A history of ‘‘trauma’’ was reported in 13 cases. Three of
these were chemical injuries associated with ocular surface
complications. Four injures were associated with organic
matter and the remainder were associated with nonorganic
matter. The proportion of yeast and filamentary fungal
infections associated with trauma were similar (Table 1).
At presentation, 36/112 (32.1%) cases were on topical
corticosteroid (Table 1), 11/112 (9.8%) were on systemic
immunosuppression, 5/112 (4.5%) had diabetes mellitus,
and 1/112 (0.9%) had a known diagnosis of human immu-
nodeficiency virus (HIV) infection. In the univariate anal-
ysis there was evidence that filamentary fungal infections
were less frequently associated with steroid use at presenta-
tion than yeast infections (Table 5).
In a multivariable logistic regression model comparing
risk factors for filamentary fungal infection with yeast infec-
tion, filamentary fungal infection was independently asso-
ciated with contact lens use and OSD was associated
with yeast infection (Table 5). The other factors were
not statistically significant at the 5% level, and were there-
fore dropped from the model. Excluding the cases acquired
outside the UK, the model produced very similar results in
terms of significant factors and their effect size, with no
change in inference (Table 5).
 COMPARISON WITH THE 1994–2006 SERIES: We reana-
lyzed a subset of the previously reported study from Moor-
fields Eye Hospital that included only patients presenting
during whole calendar years (January 1, 1994 through
December 31, 2006).27 This earlier series only included
cases that were both UK-acquired and culture positive.
It pre-dated the routine use of IVCM. There were 59
culture-positive FK cases during this 13-year period
(1994–2006), representing an average of 4.5 cases per
year. To compare the 1994–2006 series with the 2007–
2014 series, we excluded cases in the later series that
were acquired outside the UK or did not have a positive
culture. There was evidence of a statistically significant
increase in the annual number of culture-positive, UK-ac-
quired FK presenting between 1994 and 2014: Poisson
regression P ¼ .003 (Figure 1, Lower left). During the
1994–2006 period there were 35/59 (59.3%) yeast infec-
tions and 24/59 (40.7%) filamentary fungal infections.
Fusarium was the cause of 11/59 infections (18.6%). Spe-
cific risk factors were associated with the type of microor-
ganism: 18 of 35 (51.4%) yeast infections and 9 of 24
(37.5%) filamentary fungal cases were associated with
OSD, whereas 6 of 24 (25.0%) filamentary fungal cases
and 1 of 35 (2.9%) yeast cases were associated with CL use.
DISCUSSION
THE DIAGNOSIS AND MANAGEMENT OF FUNGAL KERATITIS
is continuing to evolve. In tropical regions fungal keratitis
FIGURE 2. Diagnostic modality by which a diagnosis of fungal
keratitis was made for the 112 cases. One biopsy was from a full
excision biopsy at the time of penetrating keratoplasty.
IVCM[ in vivo confocal microscopy.
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is common and can account for over half of all microbial
keratitis cases.7–14 In temperate regions, such as the UK, it
has been a relatively uncommon diagnosis.17,27 Therefore,
it may not be considered as a potential diagnosis by
clinicians when assessing a new case of suppurative
keratitis. However, patterns of infectious diseases change
and it is important to monitor the spectrum of isolated
pathogens and their associated epidemiology. In this study
we report several clinically significant changes in the
pattern of fungal keratitis cases presenting to Moorfields
Eye Hospital during 8 consecutive years, from 2007 to
2014. This study follows a similar report covering the
preceding 13 years (1994–2006).27
We found a statistically significant increase in the number
of FK cases presenting annually to this hospital during the
2007–2014 study period. Moreover, this change may be
part of a long-term increase: the average annualized rate
for the 2007–2014 period was 14 cases per year, whereas
for the previously reported 1994–2006 period it was 4.5 cases
per year.27 The numbers of cases presenting during the first 2
years of the present series (2007 and2008) are comparable to
the typical rates in the preceding 13 years. However, there
were some differences in the case ascertainment methodol-
ogy between the 2 series thatmight explain part of this over-
all rate difference. The 1994–2006 study only included
individuals who had a positive culture and who acquired
their infection inside the UK. When we apply the same
inclusion criteria to the 2007–2014 series (acquired in the
UK with a positive culture) the rate is 9.3 cases per year.
This rate is twice that of the 1994–2006 series. It is possible
that someof this increase is explainedby amodest expansion
of the referral base since 2007, with a growth of theUK pop-
ulation, particularly in London and the southeast of England
and a slight consolidation of ophthalmic emergency work
into fewer centers. However, the increase is of a sufficient
magnitude to suggest that there might be an underlying
increase in the population level incidence of fungal keratitis,
which warrants further investigation with a national survey
and case-control study.
FIGURE 3. In vivo confocal microscopy images of fungal keratitis: (a) branching filamentary fungal elements, (b) multiple large
round yeast bodies.
TABLE 3. Analysis of Fungal Species in 79 Cases With a
Cultured Isolate, Presenting Between 2007 and 2014
Fungal Species n/79 (%)
One filamentary fungal isolate
Fusarium sp 26 (32.9%)
Aspergillus sp 7 (8.9%)
Scopulariopsis brevicaulis 1 (1.3%)
Acremonium 2 (2.5%)
Paecilomyces 1 (1.3%)
Rhizomucor 1 (1.3%)
Scedosporium apiospermum 1 (1.3%)
Cladosporium 1 (1.3%)
Curvelaria 1 (1.3%)
Species not defined 1 (1.3%)
Subtotal 42 (53.2%)
Two filamentary fungal isolates
Fusarium sp þ Acremonieum 2 (2.5%)
Fusarium sp þ Gibberella fujikuroi 1 (1.3%)
Fusarium sp þ Purpureocillium lilacinum 1 (1.3%)
Fusarium sp þ Scedosporium apiospermum 1 (1.3%)
Aspergillus sp þ Chrysosporium 1 (1.3%)
Aspergillus sp þ Scedosporium apiospermum 1 (1.3%)
Subtotal 7 (8.9%)
Yeasts only
Candida sp 26 (32.9%)
Subtotal 26 (32.9%)
Yeast and filamentary fungal isolates
Candida sp þ Fusarium sp 2 (2.5%)
Candida sp þ Paecilomyces 1 (1.3%)
Candida sp þ Achromobacter xylosoxidans 1 (1.3%)
Subtotal 4 (5.2%)
Total 79 (100%)
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In addition to an overall increase in fungal keratitis,
there has also been a change in the pattern of organisms
identified. Much of the additional fungal keratitis present-
ing in recent years has been driven by an increase in
filamentary fungal infections. We found no evidence for a
rise in yeast infections. Historically, fungal keratitis in
temperate regions has tended to be dominated by yeast
infections.17–26 In the 1994–2006 Moorfields series yeasts
accounted for around 60% of all cases.27 However, in the
2007–2014 series the situation has reversed, with yeasts
identified in 25%, filamentary organisms in 70%, and
mixed infections in 5%. The most frequent filamentary
organisms identified were Fusarium spp, followed by Asper-
gillus spp, which is consistent with many case series from
around the world. The increase in cultured filamentary
fungi was dominated by an increase in Fusarium spp from
18% in the 1994–2006 series to 42% in 2007–2014.
The leading risk factors for fungal keratitis were contact
lens use and OSD, although there appears to have been a
recent change in their relative contribution. In the
1994–2006 series only 12% of all fungal keratitis cases
were contact lens associated.27 In the current series this
has risen to 57%. The risk factor associations for yeast
and filamentary infections were quite distinct. Two-thirds
of the filamentary cases were associated with contact lens
use, in contrast to only a quarter of the yeast cases.
The large majority of these were soft contact lenses. Given
the long-term retrospective nature of this study, we were
unable to ascertain the specific lenses being used or the
related contact lens solutions. However, in view of the
experience in 2005 and 2006 when there was an outbreak
of fungal keratitis in the United States and Singapore
(and a small number of cases in Europe) associated with
the use of the ReNu with MoistureLoc (Bausch & Lomb)
contact lens solution, it would now seem appropriate that
the possibility that this apparent rise in the number of fila-
mentary fungal cases was associated with contact lens use is
prospectively investigated.17,37–42
A prior history of chronic ocular surface disease was
much more frequently associated with yeast infections.
This observation is consistent with the earlier studies
from the UK.17,27 A history of anterior segment surgery
and prior steroid use were more frequently associated
with yeast infections; however, in a multivariable analysis
these effects were not independent risk factors for yeast,
probably because they were correlated with OSD.
This study illustrates the challenges in making a diag-
nosis of fungal keratitis and the importance of using several
different approaches. The ability to confirm the diagnosis is
often held back by relatively low rates of positive cultures.
Our ability to diagnose fungal infections has been greatly
enhanced by IVCM since 2006. We often find clear
IVCM evidence of fungal hyphae in cases that are clinically
suspected to be fungal in etiology, but fromwhich an organ-
ism cannot be cultured despite repeated attempts, such as
in the 28 we report here (Figure 2). However, it is impor-
tant that the image interpretation be done by an experi-
enced observer to avoid potential confusion with other
linear structures, such as corneal nerves or artefacts.36
The use of a panfungal PCR assay only entered our routine
practice in the last 24 months of the study period. It was
therefore not included in the analysis of the diagnostic
modalities so that a consistent approach was applied
TABLE 5. Analysis of Associations Between Filamentary
Fungi and Yeast (Excluding the Mixed Fungal Infection
Cases) and Risk Factors for 106 Fungal Keratitis Cases and
the 86 Cases Acquired in the United Kingdom, Presenting
Between 2007 and 2014
Variable OR 95% CI P Value
(A) All cases (n ¼ 106)
Univariate analysis
Contact lens 6.00 2.26–15.9 .0003
OSD 0.09 0.03–0.24 <.0001
Ocular surgery 0.16 0.06–0.44 .0003
Trauma 0.78 0.22–2.77 .7
Prior steroid use 0.18 0.07–0.46 .0003
Multivariable logistic regression model
Contact lens 4.35 1.50–12.7 .0070
OSD 0.11 0.04–0.33 .0001
(B) UK-acquired cases only (n ¼ 86)
Univariate analysis
Contact lens 6.30 2.16–18.3 .0007
OSD 0.09 0.03–0.28 <.0001
Ocular surgery 0.14 0.05–0.42 .0004
Trauma 1.63 0.32–8.29 .6
Prior steroid use 0.11 0.04–0.32 .0001
Multivariable logistic regression model
Contact lens 4.42 1.38–14.1 .012
OSD 0.12 0.04–0.40 .0005
CI ¼ confidence interval; OR ¼ odds ratio; OSD ¼ ocular
surface disease.
TABLE 4. Bacterial Co-infections Cultured From Cases of
Fungal Keratitis, Presenting Between 2007 and 2014
Microorganism n/112 Percentage (%)
Gram-positive bacteria
Coagulase-negative staphylococcus 7 (6.3%)
Staphylococcus epidermidis 2 (1.8%)
Staphyloccous aureus 2 (1.8%)
Staphylococcus capitis 1 (0.9%)
Corynebacterium 1 (0.9%)
Microbacterium oxydans 1 (0.9%)
Brevibacterium 1 (0.9%)
Gram-negative bacteria
Pseudomonas aeruginosa 3 (2.7%)
Klebsiella 1 (0.9%)
Enterococcus faecalis 1 (0.9%)
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throughout the period. It is noteworthy that during
the study period, PCR did not detect any additional
cases that were not detected by 1 or more other diagnostic
investigations.
We consider the finding of fungal hyphae identified by
light microscopy of stained material from the cornea to
be diagnostic for fungal keratitis. However, we are
concerned that this is an increasingly neglected test.
Moreover, special stains such as lactophenol blue or calco-
fluor white, which may enhance the detection fungal
hyphae, may not be routinely performed. Therefore, good
communication between ophthalmology and microbiology
services is important to maximize the possibility of a posi-
tive identification.
There is limited clinical evidence to guide the choice of
treatments for FK. During the period being studied (2007–
2014), there were 2 shifts in our topical prescribing practice
for filamentary fungal infections. First, from 2009 we
started using voriconazole 1% instead of econazole 1%.
More recently (from 2013) we changed from voriconazole
1% to natamycin 5%. This change was informed by the
results of the MUTT1 trial from South India, which found
natamycin 5% to be superior to voriconazole 1%, particu-
larly for the treatment of Fusarium.43 In cases that are
unresponsive to either natamycin 5% or voriconazole
1%, our second-line treatment is chlorhexidine 0.2%.44
When yeast has been identified we treat with either
amphotericin 0.15% or voriconazole 1%. Our experience
has been that fungal infections can usually be controlled
in the large majority of patients with these agents,
indicated by the low number of eyes that needed to be evis-
cerated in this series. However, very prolonged courses of
topical therapy for several months may be needed.35,45
Retrospective studies such as this one have several limi-
tations. Firstly, we may not have identified all possible cases
and there is a lack of a standardized data recording process.
Some patients were referred by other ophthalmic units
where they might have received some treatment, poten-
tially making the identification of fungal organisms at our
center less likely. We do not have systematic data on pre-
treatment. Secondly, as it was not a population-based
study, we cannot be certain that the changes observed
are due to an underlying increase in the incidence of FK,
rather than a change in referral patterns or case ascertain-
ment. Thirdly, in the absence of an appropriate control
group we are unable to investigate specific risk factors
further, beyond reporting the observations of their relative
frequency among cases. Despite these limitations, it is
possible to draw several clinically significant conclusions
of which ophthalmologists practicing in the UK and
possibly in other similar countries need to be aware. Firstly,
there are reasonable grounds to think that fungal keratitis
has become more frequent in recent years. Secondly, there
has been a relative increase in the proportion of filamentary
fungal cases, which has implications for the choice of anti-
fungal treatment. Thirdly, a greater proportion of cases are
now associated with the prior use of contact lenses. Taken
together, these observations suggest that more detailed
investigation with case-control study methodology and a
national surveillance study are warranted.
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